---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-033912"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2022-03-15T23:59:59+00:00"
generated_at: "2026-06-26T22:42:53.230544+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Esperion CFO Richard Bartram to step down effective April 8, 2022

## Summary
- CFO, Principal Financial Officer and Principal Accounting Officer Richard B. Bartram departing.
- Departure effective April 8, 2022; no successor named in filing.
- Decision not due to any disagreement with company operations, policies or practices.

## SEC filing metadata
- accession: 0001104659-22-033912
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2022-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/0001104659-22-033912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/tm229356d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-033912
- JSON: https://secwatch.observer/filing/0001104659-22-033912.json
- Plain text: https://secwatch.observer/filing/0001104659-22-033912.txt

## Key facts
- Executive change
  Richard B. Bartram departed as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer at Esperion Therapeutics, Inc..
  - Action: stepping down
  - Role: Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
  source text: On March 15, 2022, Esperion Therapeutics, Inc. (the “Company”) announced that Richard B. Bartram was stepping down from his positions as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective as of April 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434868/000110465922033912/0001104659-22-033912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.